Anti-inflammatory approaches to ischaemic stroke prevention

Stroke is a major cause of neurological morbidity and mortality. Atherosclerosis is a major contributor to first and recurrent stroke. A growing evidence base indicates that inflammation is a key process in the pathogenesis of atherosclerosis, leading to thromboembolic events. In this review, we sum...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of neurology, neurosurgery and psychiatry Vol. 89; no. 2; pp. 211 - 218
Main Authors:	Kelly, Peter J, Murphy, Sean, Coveney, Sarah, Purroy, Francisco, Lemmens, Robin, Tsivgoulis, Georgios, Price, Chris
Format:	Journal Article
Language:	English
Published:	England BMJ Publishing Group LTD 01.02.2018
Subjects:	Anti-Inflammatory Agents - therapeutic use Atherosclerosis Brain Ischemia - immunology Brain Ischemia - prevention & control C-Reactive Protein - immunology Cardiac arrhythmia Cardiovascular disease Clinical trials Colchicine - therapeutic use Coronary Disease - immunology Coronary vessels Dementia Disease prevention Embolisms Health risk assessment Heart attacks Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Inflammation Inflammation - immunology Intracranial Arteriosclerosis - immunology Plaque, Atherosclerotic - immunology Proteins Recurrence Stroke Stroke - immunology Stroke - prevention & control Studies Systematic review Uric acid stroke
ISSN:	0022-3050, 1468-330X, 1468-330X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!